• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1184

Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)

Intended Use: Intended for use as a general-purpose sweetener in foods, excluding infant formula and meat and poultry products, at levels determined by good manufacturing practices.
Basis: Scientific procedures
Notifier: Sichuan Ingia Biosynthetic Co., Ltd.
Notifier Address: 2-1111#, No. 368 Tianfu 2nd Street, Hi-tech Zone
Chengdu, Sichuan, 610041
China
FDA's Letter: Pending
-
-